Octreotide Acetate
Product Images NDC 25021-463

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Octreotide Acetate (NDC 25021-463). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amino Acid Sequence (Oct05 0010 01)

Chemical structure of octreotide acetate showing its amino acid sequence with specific residues labeled, including Phe, Trp, Lys, Thr, and Cys, as well as a methyl group (CH3).*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Oct05 0010 02)

Label for Octreotide Acetate Injection by Sagent Pharmaceuticals showing 1,000 mcg per 5 mL (200 mcg per mL) strength. The label indicates a 5 mL multi-dose vial for subcutaneous or intravenous use. It includes storage instructions and lists key inactive ingredients such as sodium chloride and phenol.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Oct05 0010 03)

Label for Octreotide Acetate Injection by Sagent Pharmaceuticals showing 5,000 mcg per 5 mL (1,000 mcg per mL) strength in a 5 mL multi-dose vial for subcutaneous or intravenous use. It includes storage instructions, ingredient details, and usage guidelines with the NDC 25021-467-05.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Oct05 0010 04)

Label for Octreotide Acetate Injection, 50 mcg per mL, in a 1 mL single-dose vial. The label states it is preservative-free and intended for subcutaneous or intravenous use. Manufactured for Sagent Pharmaceuticals and made in Canada. Includes NDC 25021-463-01 and a barcode.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Oct05 0010 05)

Label for Octreotide Acetate Injection, 100 mcg per mL, in a 1 mL single-dose vial. The label indicates it is preservative-free and intended for subcutaneous or intravenous use. Manufactured for Sagent Pharmaceuticals and made in Canada. Includes an NDC code and barcode.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Oct05 0010 06)

Label for Octreotide Acetate Injection 500 mcg per mL, 1 mL single-dose vial by Sagent Pharmaceuticals. The label states it is preservative-free and meant for subcutaneous or intravenous use, with a note to discard unused portion. The product is made in Canada.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.